74. Glimelius B, Tiret E, Cervantes A, Arnold D. Rectal cancer:
ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2013;24:vi81–vi8.
75. Sargent D, Sobrero A, Grothey A, et al. Evidence for cure
by adjuvant therapy in colon cancer: observations based
on individual patient data from 20,898 patients on 18 randomized trials. J Clin Oncol 2009;27:872–7.
76. Graham RA, Wang S, Catalano PJ, Haller DG. Postsurgical surveillance of colon cancer: preliminary cost analysis
of physician examination, carcinoembryonic antigen testing, chest x-ray, and colonoscopy. Ann Surg 1998;228:59.
77. Castells A, Bessa X, Daniels M, et al. Value of postoperative surveillance after radical surgery for colorectal cancer.
Dis Colon Rectum 1998;41:714–23.
78. Primrose JN, Perera R, Gray A, et al. Effect of 3 to 5 years
of scheduled CEA and CT follow-up to detect recurrence
of colorectal cancer: the FACS randomized clinical trial.
79. Bruinvels DJ, Stiggelbout AM, Kievit J, et al. Follow-up of
patients with colorectal cancer. A meta-analysis. Ann Surg
80. Litvak A, Cercek A, Segal N, et al. False-positive elevations of carcinoembryonic antigen in patients with a history
of resected colorectal cancer. J Natl Compr Canc Netw
81. Shimwell NJ, Wei W, Wilson S, et al. Assessment of novel
combinations of biomarkers for the detection of colorectal
cancer. Cancer Biomarkers 2010;7:123–32.
82. Carpelan-Holmström M, Louhimo J, Stenman U-H, et al.
Estimating the probability of cancer with several tumor
markers in patients with colorectal disease. Oncology
83. Chau I, Allen MJ, Cunningham D, et al. The value of routine serum carcino-embryonic antigen measurement and
computed tomography in the surveillance of patients after
adjuvant chemotherapy for colorectal cancer. J Clin Oncol
84. Pita-Fernández S, Alhayek-Aí M, González-Martín C, et
al. Intensive follow-up strategies improve outcomes in non-metastatic colorectal cancer patients after curative surgery. A systematic review and meta-analysis. Ann Oncol
85. Jeffery M, Hickey BE, Hider PN. Follow-up strategies for
patients treated for no-metastatic colorectal cancer. Cochrane Database Syst Rev. 2007;( 1):CD002200.
86. Baca B, Beart Jr RW, Etzioni DA. Surveillance after
colorectal cancer resection: a systematic review. Dis Colon
87. Gall CA, Weller D, Esterman A, et al. Patient satisfaction
and health-related quality of life after treatment for colon
cancer. Dis Colon Rectum 2007;50:801–9.
88. Traa MJ, Orsini RG, Oudsten BLD, et al. Measuring the
health-related quality of life and sexual functioning of patients with rectal cancer: Does type of treatment matter?
Int J Cancer 2014;134:979–87.
89. McMullen CK, Hornbrook MC, Grant M, et al. The greatest
challenges reported by long-term colorectal cancer survivors with stomas. J Support Oncol 2008;6:175–82.
90. Emmertsen KJ, Laurberg S. Impact of bowel dysfunction
on quality of life after sphincter‐preserving resection for
rectal cancer. Br J Surg 2013;100:1377–87.
91. Mols F, Beijers T, Lemmens V, et al. Chemotherapy-induced neuropathy and its association with quality of life
among 2-to 11-year colorectal cancer survivors: results
from the population-based PROFILES registry. J Clin
92. Stoffel EM, Mangu PB, Gruber SB, et al. Hereditary
colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline Endorsement of
the Familial Risk–Colorectal Cancer: European Society
for Medical Oncology Clinical Practice Guidelines. J Clin